Mills-Peninsula Newsroom

Mills Receives Stroke Care Award

StrokeGold_2016For the sixth year in a row, Mills-Peninsula Health Services has received the American Heart Association/American Stroke Association’s (AHA/ASA) Stroke Gold Plus award for high-quality stroke care. The award recognizes Mills-Peninsula for treating stroke patients with 85 percent or higher compliance to AHA/ASA standards of care for at least two consecutive years and achieving 75 percent or higher compliance with five of eight stroke quality measures.

The quality measures include aggressive use of medications, such as antithrombotics, anticoagulation therapy, deep vein thrombosis prophylaxis, cholesterol reducing drugs and smoking cessation – all aimed at reducing death and disability and improving the lives of stroke patients.

“Our expert stroke team is dedicated to providing the highest quality care for our patients,” says Janet Wagner, Mills-Peninsula CEO. “We are honored to be recognized by the American Heart Association and American Stroke Association with the Gold Plus award for quality and timely stroke treatment.”

Mills-Peninsula also received the Target: Stroke Honor Roll Elite recognition for quickly treating stroke patients with tissue plasminogen activator (tPA), the drug that breaks up clots that cause a stroke. The Honor Roll Elite designation means that during the past quarter, at least 75 percent of Mills-Peninsula’s eligible ischemic stroke patients received tPA within 60 minutes of arrival to the hospital (known as door-to-needle time).

AHA/ASA’s Get With The Guidelines is a national quality-improvement program for hospitals designed to ensure care for cardiac and stroke patients follows the most up-to-date, evidence-based guidelines and recommendations.